Excelitas Technologies acquires Phoseon

Phoseon, which makes LED curing systems, has been acquired by Excelitas Technologies, which makes photonic solutions for a range of different applications including illumination, optronic and sensing, for both OEM and end-user customers.

Excelitas Technologies was founded in 2010 and acquired by the New York based private equity firm AEA Investors in December 2017. Since then the company has acquired four other companies with Phoseon being the fifth. Excelitas Technologies draws customers from a number of different markets, including biomedical, scientific, semiconductor, industrial manufacturing and consumer products as well as defense and aerospace. It employs some 7,500 staff with operations in North America, Europe and Asia.

Paul Brierley, Vice President Lighting at Excelitas Technologies, commented: “I am delighted to welcome the Phoseon team to the Excelitas family. Phoseon’s core capabilities in LED innovation and manufacturing ideally complement our existing technology offering and provide an excellent opportunity for expanded R&D cooperation to better serve our customers.” 

He added: “Furthermore, Phoseon’s compelling standard product portfolio promises tremendous growth when combined with our expansive global channel sales network. We are enthused with the prospect of offering the markets our extensive reach and broader range of UV LED solutions.”

Phoseon was set up in 2002 and initially concentrated on developing industrial curing solutions, including UV ink curing systems for printing presses. The company has also explored using its technology for life sciences such as research, detection and disinfection, setting up a dedicated division during the pandemic. Phoseon will continue to operate from its base in Oregon, USA. 

Bill Cortelyou, President and CEO of Phoseon Technology, noted: “Phoseon’s market strength in UV curing for the printing, coatings and finishing sectors is a perfect fit with Excelitas’ proven leadership in UV curing for the medical device and electronics manufacturing space. Together, we offer comprehensive sales and support for curing solutions across the broadest possible range of applications.” He added: “We are extremely pleased with the strong support and seamless integration that this partnership will create. We see increased LED and UV innovation forthcoming and expect significant growth in this new partnership.”

You can find further details on both companies from phoseon.com and excelitas.com.


Posted

in

, ,

by

Syndicate content

You can license the articles from Printing and Manufacturing Journal to reproduce in other publications. I generally charge around £150 per article but I’m open to discussing this for each title, particularly for publishers that want to use multiple stories. I can provide high res versions of images for print publications.

I’m used to working with overseas publishers and am registered for VAT with the UK’s HMRC tax authority but obviously won’t charge VAT to companies outside the UK. You can find further details and a licensing form from this page, or just contact me directly here.

Support this site

If you find the stories here useful then please consider making a donation to help fund Printing and Manufacturing Journal, either as a one-off or a repeat payment. Journalism is only really useful if it’s truly independent and this is the only such news source serving the print/ manufacturing sectors.

However, there are costs involved in travelling to cover events, as well as maintaining this site, not to mention the time that it takes to carry out research, check facts and interview people. So if you value this work, then please help to maintain it and keep it free to read.

Subscribe

Never miss a story – subscribe to Printing and Manufacturing Journal to receive an email notification every time an article is published here. It’s completely free of charge and you can cancel the subscription at any point without any hassle. There’s no need to provide any information other than an email address and subscribers details are not for sale so there’s no risk of any further marketing spam.

Related stories

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *